Quest Diagnostics (DGX)
Health Care0 articles
Price chart
Quest Diagnostics (DGX) overview
Quest Diagnostics is a leading provider of clinical laboratory testing. It is a member of the S&P 500 and is classified in the Health Care sector — pharmaceutical, biotech, device and managed-care companies.
Quest Diagnostics trades on the NYSE under the ticker symbol DGX. As of the most recent market data, the stock was priced around $210.68, up 0.61% on the session, giving Quest Diagnostics a market capitalization of roughly $23.32B.
Over the past 52 weeks, DGX has traded between $165.30 and $219.20. Shares are valued at a trailing price-to-earnings (P/E) ratio of about 23.2, a common gauge of how richly the market prices the company's earnings. Quest Diagnostics also pays a dividend, currently yielding around 1.64%.
Key statistics
Informational only, not financial advice. Content is AI-generated and may contain errors. How this works.
Why investors watch DGX
As one of the larger companies in the Health Care sector, Quest Diagnostics is closely followed by investors and often moves with broader trends across pharmaceutical, biotech, device and managed-care companies. Traders watch DGX for earnings reports, analyst rating changes, and headlines that can shift sentiment — each of which is summarized on this page as it breaks.
No news stories for Quest Diagnostics have come through our feed yet. New DGX articles will appear here automatically as they are published — meanwhile, explore the overview, sector, and guides below.
More Health Care stocks
Frequently asked questions
Is Quest Diagnostics in the S&P 500?
Yes. Quest Diagnostics (DGX) is a member of the S&P 500 index, classified in the Health Care sector.
What sector is DGX in?
Quest Diagnostics is classified in the Health Care sector of the S&P 500 — pharmaceutical, biotech, device and managed-care companies.
Where can I find the latest DGX news?
This page collects recent Quest Diagnostics (DGX) news and market analysis, each article summarized by AI and tagged with bullish, bearish, or neutral sentiment.
What is Quest Diagnostics's stock price?
As of the most recent market data, Quest Diagnostics (DGX) traded at approximately $210.68. Prices move throughout the trading day, so this reflects the latest available quote rather than a live price.
What is Quest Diagnostics's market cap?
Quest Diagnostics has a market capitalization of roughly $23.32B, based on its most recent share price and shares outstanding.
What is DGX's P/E ratio?
DGX trades at a trailing price-to-earnings ratio of about 23.2. The P/E ratio compares a company's share price to its earnings per share.